hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.95
+0.45 (6.92%)
Oct 10, 2025, 4:39 PM GMT+1
hVIVO Market Cap
hVIVO has a market cap or net worth of 47.29 million as of October 10, 2025. Its market cap has decreased by -75.35% in one year.
Market Cap
47.29M
Enterprise Value
38.70M
Revenue
54.47M
Ranking
n/a
PE Ratio
9.04
Stock Price
6.95
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 47.29M, an increase of 174.32%. That is a compound annual growth rate of 17.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 47.29M | -66.10% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | 172.36M | 1,388.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.58B |
| GSK plc | 65.20B |
| Haleon | 30.37B |
| Smith & Nephew | 11.52B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.68B |